Endymed Ltd

Tel Aviv Stock Exchange ENDY.TA

Endymed Ltd Interest Coverage Ratio for the year ending December 31, 2023: 30.17

Endymed Ltd Interest Coverage Ratio is 30.17 for the year ending December 31, 2023. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Endymed Ltd Interest Coverage Ratio for the year ending December 31, 2021 was 61.25, a 665.62% change year over year.
Endymed Ltd Interest Coverage Ratio for the year ending December 31, 2020 was 8.00, a -94.09% change year over year.
Endymed Ltd Interest Coverage Ratio for the year ending December 31, 2019 was 135.31.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Tel Aviv Stock Exchange: ENDY.TA

Endymed Ltd

CEO	Mr. Yossi Bar-On CPA
IPO Date	July 19, 2007
Location	United States
Headquarters	4400 Route 9 South
Employees	46
Sector	Consumer Discretionary
Industries Cosmetics Pharmaceuticals

Description

Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, body contouring, texture enhancement, cellulite reduction, circumferential reduction, acne and acne scar reduction, stretch mark reduction, RF micro needling, and fractional resurfacing. The company was founded in 2007 and is based in Freehold, New Jersey.

Key trends

Past 5 years